Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab
Sign Up to like & getrecommendations! Published in 2020 at "International Journal of Laboratory Hematology"
DOI: 10.1111/ijlh.13384
Abstract: Dear Editors: Development of antibodies interfering with the function of factor VIII (FVIII) replacement products is one of the most significant complications in the treatment of hemophilia A (HA). Laboratory testing for such antibodies, called… read more here.
Keywords: plasma; bethesda assay; treatment; fviii ... See more keywords